🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of the study is to evaluate the safety and immunogenicity of a ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2010-04
Trial ID
NCT01110044
Treatments Being Tested
BEATRIX (group B strEptococcus mATeRnal and Infant VaX study) The purpose o...
Status
Recruiting
Location
Center for Research in Women's Health
Start Date
2025-08-25
Trial ID
NCT07160244
The purpose of this primary vaccination study is to evaluate the immunogeni...
Status
Completed
Location
Multiple Locations
Start Date
2002-03
Trial ID
NCT00135486
Treatments Being Tested
This protocol posting deals with objectives \& outcome measures of the exte...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-05
Trial ID
NCT00322335
The purpose of this trial is to assess if the rate of febrile reactions fol...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-07-02
Trial ID
NCT00496015
Primary Objective: * To demonstrate that ProQuad® can be administered conc...
Status
Completed
Location
Multiple Locations
Start Date
2007-01-12
Trial ID
NCT00432042
Treatments Being Tested
The purpose of this study was to assess the safety and immunogenicity of GS...
Status
Completed
Location
GSK Investigational Site
Start Date
2021-05-26
Trial ID
NCT04535037
Treatments Being Tested
This protocol posting deals with objectives \& outcome measures of an exten...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-05-14
Trial ID
NCT00891176
The purpose of the present study is to demonstrate that the changes in the ...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-01-05
Trial ID
NCT00808444
The purpose of this primary vaccination phase is to demonstrate the non-inf...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-04
Trial ID
NCT00327184